NCT01860066 - A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD | Biotech Hunter

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

QVA149

QVA149 via inhaler twice a day

DRUG

fluticasone/salmeterol

fluticasone/salmeterol via inhaler twice a day

Trial Locations (31)

1000

Novartis Investigative Site, Brussels

1425

Novartis Investigative Site, Buenos Aires

2060

Novartis Investigative Site, Antwerp

3500

Novartis Investigative Site, Hasselt

3600

Novartis Investigative Site, Genk

4000

Novartis Investigative Site, San Miguel de Tucumán

5100

Novartis Investigative Site, Jambes

5500

Novartis Investigative Site, Mendoza

6060

Novartis Investigative Site, Gilly

302004

Novartis Investigative Site, Jaipur

388225

Novartis Investigative Site, Karamsad

411004

Novartis Investigative Site, Pune

C1115AAB

Novartis Investigative Site, Buenos Aires

C1122AAK

Novartis Investigative Site, Buenos Aires

Unknown

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Florida Blanca

Novartis Investigative Site, Medellín

M5500CBA

Novartis Investigative Site, Mendoza

471 54

Novartis Investigative Site, Cvikov

377 01

Novartis Investigative Site, Jindřichův Hradec

360 66

Novartis Investigative Site, Karlovy Vary

664 34

Novartis Investigative Site, Kuřim

530 09

Novartis Investigative Site, Pardubice

415 01

Novartis Investigative Site, Teplice

697 70

Novartis Investigative Site, Kyjov

522 001

Novartis Investigative Site, Guntur

380 008

Novartis Investigative Site, Ahmedabad

121 001

Novartis Investigative Site, Faridabad

560 002

Novartis Investigative Site, Bangalore

400 012

Novartis Investigative Site, Nagpur